Cite

    David I Bernstein et al.. “Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial.” Lancet infectious diseases, vol. 20, no. 1, 2020, pp. 80–91. http://access.bl.uk/ark:/81055/vdc_100098074840.0x000018